Summary Info
No Summary

NAV Details

NAV Date : 17-Dec-12
NAV [Rs.] : 10.0
Buy/Resale Price [Rs.] : 0.00
Sell/Repurchase Price [Rs.] : 0.00
Entry Load % : Nil
Exit Load % : Nil

NAV Chart

Graph: 1m |   3m |   6m |   1y |   3y
No Chart

Performance(%)

* returns above 1 yr. are annualized

No Performance

Latest Payouts

  Dividends Bonus
Ratio NA NA
Date NA NA

Investment Details

Tax Benefits : NA
Min. Investment(Rs.) : 5,000.00
Increm.Investment(Rs.) : 0.00

In & Out

In
Name of the Company No of shares
No fresh investments made in
Out
Name of the Company No of shares
No investments sold out

Fund Holdings

As on 31-Mar-2013

Asset TypeInstrument NameIndustryNet Assets
(%)		No of SharesMkt Value
(Cr.)
Money Market Investments
Certificate of Depositsthe south indian bank limited **A1+29.51,10011.0
Certificate of Depositsaxis bank limited **A1+26.81,00010.0
Certificate of Depositsicici bank limited **A1+26.81,00010.0
Certificate of Depositskotak mahindra bank limited **A1+16.16006.0
Cash & Cash Equivalent
Net CA & Othersnet receivable/payable-/-0.7NA0.3

My Watchlist


Schemes NAV(Rs.)
No Fund

Key Information

Fund House: 
Incorporation Date : 
Total Assets Managed (Cr.) : 
Trustee/s : 
Chairman : 
CEO / MD : 
CIO : 
President : 
Director/s : 
Compliance Officer/s : 
Investor Service Officer/s : 
Fund Manager/s : 

Other Information

Auditors : 
Registered Office : 
Contact Nos : 
Fax : 
Email :
Website : 

Fund Manager Speak

Tushar Pradhan, CIO, HSBC Mutual Fund
“Our research shows that a disciplined approach to buying companies that look attractive on this matrix provides significant longer term outperformance.”..
Vikaas Sachdeva, CEO, Edelweiss Asset Management Ltd
Kaushik Dani, Head of Equity, Peerless Funds Management Company
View all Fund Manager Speak >>

IIFL Blogs

Anu Jain
Where are we heading??
Nifty has now attempted 5000 a couple of times and retracted back to the 4900 levels. Narrow range and a small fall but at the same time indicative of a psychological barrier. It reminds one of the...
Amar Ambani
Drugs chasing Dollars - All eyes on the US Gen...
The emerging generic markets of the world are likely to outshine the US in the coming years but the fact remains that the US generic market is one of its kind - the perfect destination for the Indi...